LA+PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LA+PHARMA
Largest movements
- Cash +€119,845
up €119,845 (+42.7%), from €280,663 to €400,508
mainly Net result for the year (+€127,041) and Depreciation (+€68,950)
- Intangible fixed assets -€42,500
down €42,500 (-21.1%), from €201,875 to €159,375
- Receivables within one year +€25,079
up €25,079 (+19.7%), from €127,056 to €152,135
of which Other amounts receivable: +€26,811
- Tangible fixed assets -€20,878
down €20,878 (-4.1%), from €511,044 to €490,166
of which Land and buildings: -€18,448
- Reserves +€126,208
up €126,208 (+30.9%), from €408,398 to €534,605
- Debts after one year -€37,954
down €37,954 (-9.3%), from €408,645 to €370,691
- Tax, wage and social debts -€31,100
down €31,100 (-66.9%), from €46,470 to €15,370
of which Taxes: -€30,016
- Trade debts +€20,083
up €20,083 (+7.8%), from €257,122 to €277,205
- Depreciation -€41,623
down €41,623 (-37.6%), from €110,573 to €68,950
- Gross operating margin -€32,012
down €32,012 (-8.2%), from €391,957 to €359,945
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,354,157 | €1,443,395 | +€89,238 | +6.6% |
| Fixed assets | 21/28 | €712,919 | €649,541 | -€63,378 | -8.9% |
| Intangible fixed assets | 21 | €201,875 | €159,375 | -€42,500 | -21.1% |
| Tangible fixed assets | 22/27 | €511,044 | €490,166 | -€20,878 | -4.1% |
| Land and buildings | 22 | €479,469 | €461,021 | -€18,448 | -3.8% |
| Plant, machinery and equipment | 23 | - | €4,363 | +€4,363 | |
| Furniture and vehicles | 24 | €31,575 | €24,782 | -€6,793 | -21.5% |
| Current assets | 29/58 | €641,239 | €793,854 | +€152,615 | +23.8% |
| Stocks and contracts in progress | 3 | €212,872 | €224,633 | +€11,761 | +5.5% |
| Stocks | 30/36 | €212,872 | €224,633 | +€11,761 | +5.5% |
| Amounts receivable within one year | 40/41 | €127,056 | €152,135 | +€25,079 | +19.7% |
| Trade receivables | 40 | €112,598 | €110,867 | -€1,731 | -1.5% |
| Other amounts receivable | 41 | €14,458 | €41,268 | +€26,811 | +185.4% |
| Cash at bank and in hand | 54/58 | €280,663 | €400,508 | +€119,845 | +42.7% |
| Deferred charges and accrued income | 490/1 | €20,648 | €16,578 | -€4,070 | -19.7% |
| Total equity and liabilities | 10/49 | €1,354,157 | €1,443,395 | +€89,238 | +6.6% |
| Equity | 10/15 | €488,398 | €614,605 | +€126,208 | +25.8% |
| Contributions | 10/11 | €80,000 | €80,000 | = | 0.0% |
| Reserves | 13 | €408,398 | €534,605 | +€126,208 | +30.9% |
| Distributable reserves | 133 | €408,398 | €534,605 | +€126,208 | +30.9% |
| Amounts payable | 17/49 | €865,760 | €828,790 | -€36,970 | -4.3% |
| Amounts payable after more than one year | 17 | €408,645 | €370,691 | -€37,954 | -9.3% |
| Financial debts | 170/4 | €408,645 | €370,691 | -€37,954 | -9.3% |
| Amounts payable within one year | 42/48 | €448,319 | €448,909 | +€590 | +0.1% |
| Current portion of amounts payable after more than one year | 42 | €36,722 | €37,954 | +€1,232 | +3.4% |
| Trade debts | 44 | €257,122 | €277,205 | +€20,083 | +7.8% |
| Suppliers | 440/4 | €257,122 | €277,205 | +€20,083 | +7.8% |
| Taxes, remuneration and social security | 45 | €46,470 | €15,370 | -€31,100 | -66.9% |
| Taxes | 450/3 | €33,006 | €2,990 | -€30,016 | -90.9% |
| Remuneration and social security | 454/9 | €13,464 | €12,379 | -€1,084 | -8.1% |
| Other amounts payable | 47/48 | €108,005 | €118,380 | +€10,375 | +9.6% |
| Accrued charges and deferred income | 492/3 | €8,796 | €9,190 | +€395 | +4.5% |
| Remuneration, social security and pensions | 62 | €72,649 | €71,179 | -€1,471 | -2.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €110,573 | €68,950 | -€41,623 | -37.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €3,283 | €5,302 | +€2,020 | +61.5% |
| Other operating charges | 640/8 | €1,847 | €4,903 | +€3,056 | +165.5% |
| Gross operating margin | 9900 | €391,957 | €359,945 | -€32,012 | -8.2% |
| Operating profit (loss) | 9901 | €203,605 | €209,612 | +€6,007 | +3.0% |
| Financial income | 75/76B | €2,793 | €2,226 | -€568 | -20.3% |
| Recurring financial income | 75 | €2,793 | €2,226 | -€568 | -20.3% |
| Financial charges | 65/66B | €29,485 | €31,870 | +€2,385 | +8.1% |
| Recurring financial charges | 65 | €29,485 | €31,870 | +€2,385 | +8.1% |
| Profit (loss) for the period before taxes | 9903 | €176,914 | €179,968 | +€3,054 | +1.7% |
| Income taxes | 67/77 | €52,423 | €52,927 | +€505 | +1.0% |
| Profit (loss) for the period | 9904 | €124,491 | €127,041 | +€2,549 | +2.0% |
| Profit (loss) for the period to be appropriated | 9905 | €124,491 | €127,041 | +€2,549 | +2.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.